Next Generation News and Research

RSS

Medical device to help degenerative knee arthritis patients receives FDA approval

COTRAS Co., Ltd. (hereon referred to as COTRAS), an innovative medical-device firm focused on rehabilitation products, has secured approval from the U.S. Food and Drug Administration (FDA) for MOBILISE, a medical device to help degenerative knee arthritis patients.

8 Mar 2023

Breakthrough drug works against all the main types of primary bone cancer

Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.

8 Mar 2023

Girls in Texas could get birth control at federal clinics, until a Christian father objected

On the vast Texas Panhandle, raked by wind and relentless sun, women might drive for hours to reach Haven Health, a clinic in Amarillo.

8 Mar 2023

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

It may come as a surprise, but bacteria love to grow inside tumors. It's the environment - tumors are typically acidic, have low amounts of oxygen, and are filled with dead cells, which all facilitate bacterial growth.

6 Mar 2023

Developing tailored rehabilitation strategies for brain injury patients

More than 500,000 people in the United States undergo rehabilitation following a stroke or brain injury every year.

3 Mar 2023

UK HealthCare neurologist helps to compile an essential list of MS medications

Together with Multiple Sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.

3 Mar 2023

New cell-based assay shown to rapidly profile drug resistance to three widely used SARS-CoV-2 main protease inhibiting drugs

In a recent study posted to the bioRxiv* pre-print server, researchers tested three next-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) inhibitors, namely, nirmatrelvir, ensitrelvir, and FB2001, using a novel cell-based assay.

1 Mar 2023

Exploring the neuroprotective potential of cell-penetrating peptides, extracellular vesicles, and micro ribonucleic acids

In a recent review published in Biomedicines, researchers explored extracellular vesicles (EVs), cell-penetrating peptides (CPPs), and micro ribonucleic acids (miRNAs) as therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).

1 Mar 2023

What is the role of B cells in breast cancer pathology?

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer.

1 Mar 2023

New funding to accelerate development of potential anti-cancer compound into the clinic

For the past few decades, Dr. Iwao Ojima has been working in his Stony Brook University Department of Chemistry Laboratory and through the Institute of Chemical Biology & Drug Discovery (ICB&DD) to develop next-generation anti-cancer agents.

28 Feb 2023

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput (HT) System.

From CN Bio 28 Feb 2023

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

Researchers immunophenotyped T lymphocyte responses among unvaccinated individuals, representative of the entire spectrum of the clinical presentation of COVID-19.

28 Feb 2023

Next Generation News and Research

Medical device to help degenerative knee arthritis patients receives FDA approval

Breakthrough drug works against all the main types of primary bone cancer

Girls in Texas could get birth control at federal clinics, until a Christian father objected

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

Developing tailored rehabilitation strategies for brain injury patients

UK HealthCare neurologist helps to compile an essential list of MS medications

New cell-based assay shown to rapidly profile drug resistance to three widely used SARS-CoV-2 main protease inhibiting drugs

Exploring the neuroprotective potential of cell-penetrating peptides, extracellular vesicles, and micro ribonucleic acids

What is the role of B cells in breast cancer pathology?

New funding to accelerate development of potential anti-cancer compound into the clinic

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors

TTUHSC El Paso collaborates with Doctors of the World USA to launch the Border Health Program

Viable treatment option for patients with advanced cervical cancer

Study shows the beneficial effect of verapamil in children with newly-diagnosed type 1 diabetes

Roadmap outlines a framework for moving COVID-19 vaccines forward

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins

Structure of DREADD designer receptor could pave the way for creating next generation tools

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News